There is much debate worldwide over how governmental policies affect pharmaceutical innovation. Ensuring the safety of drugs must be offset against providing timely access to potentially life-saving or life-enhancing therapies. The authors argue that there is a need for a more balanced approach to governmental interventions.

overlay image